Long-acting injectable risperidone as an option in first-episode psychosis

Evid Based Ment Health. 2016 May;19(2):e8. doi: 10.1136/eb-2015-102207. Epub 2016 Apr 12.

Author

Nancy H Covell¹

Affiliation

¹ Psychiatry and Mental Health Services and Policy Research, Columbia University and New York State Psychiatric Institute, New York, New York, USA; covelln@nyspi.columbia.edu.

No abstract available

Publication types

Comment

MeSH terms

Antipsychotic Agents / therapeutic use
Delayed-Action Preparations / therapeutic use
Humans
Psychotic Disorders / drug therapy*
Risperidone / therapeutic use*
Schizophrenia / drug therapy

Substances

Antipsychotic Agents
Delayed-Action Preparations
Risperidone